Cargando…
Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma
Maintaining relative dose intensity (RDI) of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) improves the prognosis of patients with diffuse large B-cell lymphoma (DLBCL). Pegfilgrastim was approved in Japan in November 2014 to prevent febrile neutropenia (FN) and main...
Autores principales: | Morita, Yuka, Kanemasa, Yusuke, Sasaki, Yuki, Ohigashi, An, Tamura, Taichi, Nakamura, Shohei, Yagi, Yu, Kageyama, Akihiko, Omuro, Yasushi, Shimoyama, Tatsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913099/ https://www.ncbi.nlm.nih.gov/pubmed/35451406 http://dx.doi.org/10.1097/MD.0000000000029028 |
Ejemplares similares
-
Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report
por: Yagi, Yu, et al.
Publicado: (2021) -
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study
por: Yagi, Yu, et al.
Publicado: (2022) -
MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
por: Kageyama, Akihiko, et al.
Publicado: (2021) -
P1153: UTILITY OF THE FRAILTY SCORE FOR PREDICTING PROGNOSIS AND INDIVIDUALIZING TREATMENT INTENSITY IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Yagi, Yu, et al.
Publicado: (2023) -
Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report
por: Uematsu, Mao, et al.
Publicado: (2019)